Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-102161
Filing Date
2025-08-04
Accepted
2025-08-04 17:29:48
Documents
1
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5343
  Complete submission text file 0000950170-25-102161.txt   7002
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SALIX PHARMACEUTICALS, LTD. 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address
Forbes William P (Reporting) CIK: 0001314760 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 251181756